RECRUITINGOBSERVATIONAL
Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia
A Multicenter Non Interventional Single Arm Retrospective-prospective Observational Study in Therapeutic Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis (gMG) in Real Clinical Practice in Russia
About This Trial
This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describe real-world treatment approaches and clinical outcomes among adults with acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG) in routine clinical practice in Russia.
Who May Be Eligible (Plain English)
Who May Qualify:
1. Adults (≥18 years) diagnosed with generalized MG positive for acetylcholine receptor (AChR) antibodies.
2. Provision of signed and dated written willing to sign a consent form.
Who Should NOT Join This Trial:
1. Participants currently enrolled in clinical studies for treatment of gMG.
2. Ocular MG only.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. Adults (≥18 years) diagnosed with generalized MG positive for acetylcholine receptor (AChR) antibodies.
2. Provision of signed and dated written informed consent.
Exclusion Criteria:
1. Participants currently enrolled in clinical studies for treatment of gMG.
2. Ocular MG only.
Locations (3)
Research Site
Kazan', Russia
Research Site
Novosibirsk, Russia
Research Site
Rostov-on-Don, Russia